A Case of Cutaneous Leishmaniasis Cured by a Combined Treatment of Topical Miltefosine and Injectable Amphotericin B
Authors:
Open Access
- 8 December 2023
- journal article
- research article
- Published by Andover House Inc in Precision Nanomedicine
- Vol. 6 (4) , 1179-1190
Abstract
A male rural worker with cutaneous leishmaniasis (CL) was initially treated with repeated cy-cles of Meglumine Antimoniate (Glucantime®) and two cycles of Amphotericin B deoxycholate during a three-year period. However, the patient remained with two active lesions. An experi-mental topical treatment with liposomal Miltefosine was tested. The efficacy was determined from the MD’s inspection of the patient and analysis of the lesions’ photographic images, le-sions samples culture, and anti-Leishmania antibodies quantification. The parasites from the patient were isolated. The parasites were typified as Leishmania (Viannia) braziliensis, and their susceptibility to Miltefosine, Meglumine Antimoniate, and Amphotericin B was measured. The wound healing was initially good with the topical treat-meant, but the clinical cure was achieved only with a combination of the topical liposomal Miltefosine and intravenous Amphotericin B. Of note, the treatment efficacy was strongly corre-lated with the degree of stress suffered by the patient. To our knowledge, this is the first report on using a topical Miltefosine formulation on a CL patient.Keywords
This publication has 18 references indexed in Scilit:
- MEGA11: Molecular Evolutionary Genetics Analysis Version 11Molecular Biology and Evolution, 2021
- Efficacy of topical Miltefosine formulations in an experimental model of cutaneous leishmaniasisDrug Delivery and Translational Research, 2021
- Development and evaluation of novel miltefosine-polyphenol co-loaded second generation nano-transfersomes for the topical treatment of cutaneous leishmaniasisExpert Opinion on Drug Delivery, 2019
- Anti-leishmanial activity of a topical miltefosine gel in experimental models of New World cutaneous leishmaniasisJournal of Antimicrobial Chemotherapy, 2019
- Topical 15% Paromomycin-Aquaphilic for Bolivian Leishmania braziliensis Cutaneous Leishmaniasis: A Randomized, Placebo-controlled TrialClinical Infectious Diseases, 2018
- Topical formulations of miltefosine for cutaneous leishmaniasis in a BALB/c mouse modelJournal of Pharmacy and Pharmacology, 2016
- MLSTest: Novel software for multi-locus sequence data analysis in eukaryotic organismsInfection, Genetics and Evolution, 2013
- Three new sensitive and specific heat-shock protein 70 PCRs for global Leishmania species identificationEuropean Journal of Clinical Microbiology & Infectious Diseases, 2011
- First case of typical Old World cutaneous leishmaniasis treated with miltefosineInternational Journal of Dermatology, 2007
- Topical treatment with hexadecylphosphocholine (Miltex®) efficiently reduces parasite burden in experimental cutaneous leishmaniasisTransactions of the Royal Society of Tropical Medicine and Hygiene, 1999